Shorted
Admedus logo
AHZ

Admedus

Short interest
0.02%
+0.01 pp 30d
as of 1 May 2020
Reported shorts
962
Shares on issue
5.910M

Admedus (AHZ) company profile

Profile, insiders and operations

Company

AI-generated research profile of Admedus

biotechnology
healthcare
medical devices
innovation
ASX

Admedus is a healthcare company specializing in the development and commercialization of medical technologies. It focuses on providing innovative solutions in the field of biotechnology, particularly in regenerative medicine and tissue engineering.

Director trades

16 trades recorded

DateDirectorTypeSharesPriceValue
2026-06-22Unknown Director
buy
---
2026-06-18David Roberts
exercise options
17,580--
2026-06-05Unknown Director
buy
---
2026-06-02Susan Knight
buy
11,000--
2025-12-24Unknown Director
buy
---
2025-12-16John Daniel Seaberg
sell
27,777--
2025-12-11Unknown Director
buy
---
2025-12-03John Daniel Seaberg
other
139,386--
2025-06-05Unknown Director
buy
---
2025-05-31Wayne Geoffrey Paterson
other
4,167--
2025-03-21Unknown Director
buy
---
2025-03-20John Daniel Seaberg
exercise options
3,852--
2024-06-25Unknown Director
buy
---
2024-06-19John Daniel Seaberg
exercise options
75,000--
2024-04-02Unknown Director
buy
---
2024-03-22John Daniel Seaberg
exercise options
---

AHZ intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required